Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form

被引:33
作者
Panzade, Prabhakar S. [1 ,2 ]
Shendarkar, Giridhar R. [3 ]
机构
[1] Nanded Pharm Coll, Ctr Res Pharmaceut Sci, Sham Nagar, Nanded, India
[2] Srinath Coll Pharm, Waluj, India
[3] Nanded Pharm Coll Poly, Nanded, India
关键词
Pharmaceutical cocrystal; applications; hot-melt extrusion; bioavailability; challenges; SOLID-STATE CHARACTERIZATION; CO-CRYSTALS; PHYSICOCHEMICAL PROPERTIES; MECHANOCHEMICAL SYNTHESIS; CINNAMIC ACID; IN-VITRO; DESIGN; SOLUBILITY; DISSOLUTION; PERFORMANCE;
D O I
10.1080/03639045.2020.1810270
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pharmaceutical cocrystals are still gaining the interest of the researchers due to their potential to alter physicochemical, mechanical, and pharmacokinetic properties of active pharmaceutical ingredients without negotiating therapeutic action. The diverse new applications of cocrystals, like taste masking, reduced toxicity, patenting opportunities, commercial potential, etc. act as driving force to the rising interest of the pharmaceutical industries. Initially, cocrystals from the view of regulatory authorities, design strategies, cocrystal preparation in brief with special emphasis on scalable and solvent-free hot melt extrusion method, and practical guide to characterization have been provided. The special focus has been given to the biopharmaceutical attributes of the cocrystal. Finally, challenges before and after cocrystal preparation are presented in this review along with some commercial examples of the cocrystals.
引用
收藏
页码:1559 / 1568
页数:10
相关论文
共 111 条
[1]   Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal [J].
Aher, Suyog ;
Dhumal, Ravindra ;
Mahadik, Kakasaheb ;
Ketolainen, Jarkko ;
Paradkar, Anant .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (01) :55-60
[2]   Polymorphs, Salts, and Cocrystals: What's in a Name? [J].
Aitipamula, Srinivasulu ;
Banerjee, Rahul ;
Bansal, Arvind K. ;
Biradha, Kumar ;
Cheney, Miranda L. ;
Choudhury, Angshuman Roy ;
Desiraju, Gautam R. ;
Dikundwar, Amol G. ;
Dubey, Ritesh ;
Duggirala, Nagakiran ;
Ghogale, Preetam P. ;
Ghosh, Soumyajit ;
Goswami, Pramod Kumar ;
Goud, N. Rajesh ;
Jetti, Ram R. K. R. ;
Karpinski, Piotr ;
Kaushik, Poonam ;
Kumar, Dinesh ;
Kumar, Vineet ;
Moulton, Brian ;
Mukherjee, Arijit ;
Mukherjee, Gargi ;
Myerson, Allan S. ;
Puri, Vibha ;
Ramanan, Arunachalam ;
Rajamannar, T. ;
Reddy, C. Malla ;
Rodriguez-Hornedo, Nair ;
Rogers, Robin D. ;
Row, T. N. Guru ;
Sanphui, Palash ;
Shan, Ning ;
Shete, Ganesh ;
Singh, Amit ;
Sun, Changquan C. ;
Swift, Jennifer A. ;
Thaimattam, Ram ;
Thakur, Tejender S. ;
Thaper, Rajesh Kumar ;
Thomas, Sajesh P. ;
Tothadi, Srinu ;
Vangala, Venu R. ;
Variankaval, Narayan ;
Vishweshwar, Peddy ;
Weyna, David R. ;
Zaworotko, Michael J. .
CRYSTAL GROWTH & DESIGN, 2012, 12 (05) :2147-2152
[3]   Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin [J].
Ali, Hassan Refat H. ;
Alhalaweh, Amjad ;
Velaga, Sitaram P. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (05) :625-634
[4]   Co-crystals as a new approach to multimodal analgesia and the treatment of pain [J].
Almansa, Carmen ;
Frampton, Christopher S. ;
Miguel Vela, Jose ;
Whitelock, Steve ;
Plata-Salaman, Carlos R. .
JOURNAL OF PAIN RESEARCH, 2019, 12 :2679-2689
[5]  
[Anonymous], GUID IND REG CLASS P
[6]   Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes [J].
Arabiani, Mohsin R. ;
Lodagekar, Anurag ;
Yadav, Balvant ;
Chavan, Rahul B. ;
Shastri, Nalini R. ;
Purohit, Parva Y. ;
Shelat, Pragna ;
Dave, Divyang .
CRYSTENGCOMM, 2019, 21 (05) :800-806
[7]   Crystal Engineering of Stable Temozolomide Cocrystals [J].
Babu, N. Jagadeesh ;
Sanphui, Palash ;
Nangia, Ashwini .
CHEMISTRY-AN ASIAN JOURNAL, 2012, 7 (10) :2274-2285
[8]   Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs [J].
Baghel, Shrawan ;
Cathcart, Helen ;
O'Reilly, Niall J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2527-2544
[9]   Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations [J].
Bhardwaj, Sunny ;
Lipert, Maya ;
Bak, Annette .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (01) :31-38
[10]   Pharmaceutical cocrystals: walking the talk [J].
Bolla, Geetha ;
Nangia, Ashwini .
CHEMICAL COMMUNICATIONS, 2016, 52 (54) :8342-8360